-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 3, Sinopharm Hyundai issued an announcement stating that DALI PharmaGmbH, a wholly-owned subsidiary established by its holding subsidiary Zhijun Pharmaceuticals in Germany, received the approval of the Malta Pharmaceutical Regulatory Authority to issue ceftriaxone sodium for injection (250mg/500mg/ 1g) Marketing authorization
Its indication is that ceftriaxone sodium is a long-acting, broad-spectrum third-generation cephalosporin antibiotic.